MyMedR
Advanced
  • Browse
  • Help
  • Login
Advanced

Treatment of chronic hepatitis B virus infection in special groups of patients: decompensated cirrhosis, immunosuppressed and paediatric patients

Merican I
J Gastroenterol Hepatol, 2000 May;15 Suppl:E71-8.
PMID: 10921386

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
  • Antiviral Agents/therapeutic use
  • Child
  • Humans
  • Immunotherapy
  • Liver Cirrhosis/complications*
  • Immunocompromised Host*
  • Interferon-alpha/therapeutic use
  • AIDS-Related Opportunistic Infections/therapy
  • Hepatitis B, Chronic/complications
  • Hepatitis B, Chronic/immunology
  • Hepatitis B, Chronic/therapy*
Similar publications
  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
  • Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: a randomized trial
  • Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapy
  • Polymyositis associated with hepatitis B: management with entacavir and prednisolone
  • Treatment of chronic hepatitis C in patients with renal disease
  • Treatment of immunosuppressed chronic hepatitis B patients
  • Treatment of chronic hepatitis B in HIV co-infected patients
  • Chronic hepatitis B and herbal therapy
  • Treatment of chronic hepatitis B infection using interferon
  • Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia
  • Related publications on PubMed
Copyright © 2026 MyMedR. Developed by Rakit.

* MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.